SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

O43318 (M3K7_HUMAN) Homo sapiens (Human)

Mitogen-activated protein kinase kinase kinase 7 UniProtKBInterProSTRINGInteractive Modelling

606 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4); 21 identical sequences

Available Structures

23 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of human TAK1 kinase domain fused with TAB1monomer27-303
100
Structural Basis for the Interaction of TAK1 Kinase with its Activating Protein TAB1monomer31-305
99.62ADN;
Structure of TAK1 in complex with compound 54monomer31-303
100.0GOL;DMS;URW;
Structure of TAK1 in complex with compound 22monomer31-303
100.0GOL;DMS;UWZ;
Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 11cmonomer31-303
100.06KC;
Crystal structure of Takinib bound to TAK1monomer31-303
100.0EDH;
Crystal structure of TL10-81 bound to TAK1-TAB1monomer31-303
100.05KW;
Irreversible Inhibition of TAK1 Kinase by 5Z-7-Oxozeaenolmonomer31-303
100.010×EDO;1FM;
Crystal structure of TL10-92 bound to TAK1-TAB1monomer31-303
100.0T92;
Crystal structure of SM1-71 bound to TAK1-TAB1monomer31-303
100.06H3;
Crystal structure of TL11-128 bound to TAK1-TAB1monomer31-303
100.06L4;
Crystal Structure of type II inhibitor NG25 bound to TAK1-TAB1monomer31-303
100.0NG2;
Crystal structure of TL11-113 bound to TAK1-TAB1monomer31-303
100.06H4;
Crystal structure of compound 8 bound to TAK1-TABmonomer31-303
100.0YIY;
Crystal Structure of 1-(4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)furo[2,3-c]pyridin-4-yl]-1H-pyr…monomer31-303
100.01UL;
Crystal Structure of (1R,4R)-4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)-3-chlorofuro[2,3-c]pyridi…monomer31-303
100.01UO;EDO;
Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 4monomer31-303
100.06V5;
Crystal Structure of 2-(1-benzothiophen-7-yl)-4-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]furo[2,3-c]pyri…monomer31-303
100.01UH;
Crystal structure of CPT1691 bound to TAK1-TAB1monomer31-303
100.06HF;
Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 2monomer31-303
100.06V3;
Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 10monomer31-303
100.06JV;
Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 3monomer31-303
100.06V4;
Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 12monomer31-303
100.06KD;

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8gw3.3.Amonomer0.7825-329
92.72
7kja.1.Amonomer0.6143-358
30.84
7kja.2.Amonomer0.6143-358
30.84

9 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28gw3.3.Amonomer0.7825-329
92.72
Isoform 27kja.1.Amonomer0.6243-358
30.84
Isoform 27kja.2.Amonomer0.6143-358
30.84
Isoform 38gw3.3.Amonomer0.7925-329
92.72
Isoform 37kjc.2.Amonomer0.6343-358
30.84
Isoform 37kjc.1.Amonomer0.6243-358
MG;30.84
Isoform 48gw3.3.Amonomer0.7925-329
92.72
Isoform 47kjc.2.Amonomer0.6243-358
30.84
Isoform 47kja.1.Amonomer0.6143-358
30.84